• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE
Click for more information
3.03% 64.0¢

RECCE PHARMACEUTICALS LTD

Market Cap $130.5M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE UPDATE HIGHLIGHTS KEY DEVELOPMENTS FOR UPSIDE

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RCE
[INTERVIEW] Recce gearing up for Indonesian trials 		02/05/24 21 6.7K
02/05/24 Last post  Rykster Comments Created with Sketch.  21  Views Created with Sketch.  6.7K 
RCE
Ann: Safety Committee Approves High Dose of 4,000mg 		27/04/24 7 2.5K
27/04/24 Last post  BelowAverage Comments Created with Sketch.  7  Views Created with Sketch.  2.5K 
RCE
Ann: Recce Completes 5,000 R327 Doses Per Week under GMP 		25/04/24 44 15K
25/04/24 Last post  ToiletPaper Comments Created with Sketch.  44  Views Created with Sketch.  15K 
RCE
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		23/04/24 4 1.9K
23/04/24 Last post  Lucretious Comments Created with Sketch.  4  Views Created with Sketch.  1.9K 
RCE
Ann: Application for quotation of securities - RCE 		17/04/24 2 870
17/04/24 Last post  BelowAverage Comments Created with Sketch.  2  Views Created with Sketch.  870 
RCE
Ann: Cleansing Statement 		16/04/24 0 279
16/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  279 
RCE
Ann: Recce Pharmaceuticals - Business Update 		11/04/24 22 7.7K
11/04/24 Last post  The Ace Comments Created with Sketch.  22  Views Created with Sketch.  7.7K 
RCE
Ann: Patent Granted in Israel for RECCE Anti-Infectives 		06/04/24 8 3.1K
06/04/24 Last post  MongooseMan Comments Created with Sketch.  8  Views Created with Sketch.  3.1K 
RCE
News: RCE Recce Pharmaceuticals Says Patent Granted In Israel For RECCE Anti-Infectives 		09:55 0 178
09:55 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  178 
RCE
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial 		30/03/24 48 14K
30/03/24 Last post  BC1954 Comments Created with Sketch.  48  Views Created with Sketch.  14K 
RCE
RCE General Discussion Topics 		26/03/24 51 25K
26/03/24 Last post  zecs Comments Created with Sketch.  51  Views Created with Sketch.  25K 
RCE
[INTERVIEW] Recce reaches testing milestone for UTI, Uroseptis antibiotic 		21/03/24 0 349
21/03/24 Last post  TheMarketOnline Comments Created with Sketch.  0  Views Created with Sketch.  349 
RCE
News: RCE Recce Pharmaceuticals Says Trade Mark Registration From Canadian Intellectual Property... 		21/03/24 0 176
21/03/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  176 
RCE
Ann: RECCE Trademark Registered - Canada 		21/03/24 0 414
21/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  414 
RCE
Ann: Recce Receives AUD $11.17m R&D Advance 		21/03/24 38 10K
21/03/24 Last post  Bpharma Comments Created with Sketch.  38  Views Created with Sketch.  10K 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Safety Committee Approves High Dose of 4,000mg
26 Apr 09:42
 
Quarterly Activities/Appendix 4C Cash Flow Report
22 Apr 09:15
 
Cleansing Statement
16 Apr 19:03
 
Application for quotation of securities - RCE
16 Apr 19:00
 
Recce Completes 5,000 R327 Doses Per Week under GMP
16 Apr 09:45
 
Recce Pharmaceuticals - Business Update
08 Apr 08:41
 
View More arrow Created with Sketch.

Featured News

NEWS Oz Economic Indicators: Retail sales weakest on record & China factories hit 14mth high
right-arrow Created with Sketch.
NEWS Quarterly Wrap: Frontier Energy & Haranga Resources
right-arrow Created with Sketch.
BPH BPH Energy wraps up Q1 with $6.6M in cash but Canberra still stalling shareholders on PEP-11
right-arrow Created with Sketch.
CXO Core Lithium is running off stockpiles – and they'll be depleted by FY25
right-arrow Created with Sketch.
EV1 Evolution Energy flags successful anode testwork in potential game-changer
right-arrow Created with Sketch.
LU7 Lithium Universe visits China's Jiangsu Li-Carb facility to shore up design specifics
right-arrow Created with Sketch.

(20min delay)
Last
64.0¢ 		Change
-0.020(3.03%) 		Mkt cap ! $130.5M
Open High Low Value Volume
66.0¢ 66.0¢ 63.5¢ $29.44K 45.67K

Buyers (Bids)

No. Vol. Price($)
1 7736 64.0¢
 

Sellers (Offers)

Price($) Vol. No.
66.0¢ 33823 3
View Market Depth
Last trade - 15.48pm 02/05/2024 (20 minute delay) ?
Last
65.0¢ 		  Change
-0.020 ( 1.19 %)
Open High Low Volume
65.0¢ 65.0¢ 64.0¢ 16016
Last updated 15.59pm 02/05/2024 ?
RCE (ASX) Chart

Top Stories

Recharged Prospects: 'Watts' on the horizon for copper & lithium

The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Lithium Universe ends the quarter charged up for Quebec Refinery roll-out Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
Carnarvon revs up for revised Dorado Development The Dorado discovery appears on again, with Carnarvon Energy announcing the JV completing a revision of the project’s design to optimise capital costs and accelerate FID by the end of 2024.

Featured News

EV1 Evolution Energy flags successful anode testwork in potential game-changer
right-arrow Created with Sketch.
LU7 Lithium Universe ends the quarter on the charge for Quebec Refinery development
right-arrow Created with Sketch.
CXO Core Lithium is running off stockpiles – and they'll be depleted by FY25
right-arrow Created with Sketch.
LU7 Lithium Universe successfully locks in $3.65M to advance North American play
right-arrow Created with Sketch.
NEWS Dreadnought hits expected mineralisation through drilling at Yilgarn targets
right-arrow Created with Sketch.
HLX Gold anomalies across several kilometres impress Helix in NSW
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.